MPWT
PLRX icon

MassMutual Private Wealth & Trust’s Pliant Therapeutics PLRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-90
Closed -$2K – 1798
2022
Q3 		$2K Hold
90
– – ﹤0.01% 1267
2022
Q2 		$1K Buy
+90
New +$576 ﹤0.01% 1378

Other funds holding PLRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

MassMutual Private Wealth & Trust's PLRX Position: Q4 2022 in Review

MassMutual Private Wealth & Trust sold out of Pliant Therapeutics (PLRX) in Q4 2022, closing a stake of 90 shares — an estimated $2K sold.

MassMutual Private Wealth & Trust first reported a position in PLRX in Q2 2022 and held it in 2 quarters. The position peaked at $2K in Q3 2022. 125 funds tracked by Wall St. Rank hold PLRX as of Q4 2022.

  • MassMutual Private Wealth & Trust reported no remaining Pliant Therapeutics position as of Q4 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 90 Pliant Therapeutics shares in Q4 2022, an estimated $2K.
  • MassMutual Private Wealth & Trust first reported a position in Pliant Therapeutics in Q2 2022 and held it in 2 quarters.
  • MassMutual Private Wealth & Trust's Pliant Therapeutics position peaked at $2K in Q3 2022.
  • 125 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2022, filed 6 Jan 2023.